Accès ouvert
2026
article
OpenAlex
Jean-Francois Jabbour, Hind Kadri, ELIO JABRA, Joya-Rita Hindy et autres
This study provides the first prospective, genomically validated dataset integrated into the global MultiDrug-Resistant Organism (MDRO) Network from the Middle East and North Africa region. To address the substantial gap in antimicrobial resistance (AMR) data, the American University of Beirut Medical Center …
lb, us, sg
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Joshua T. Thaden, Felicia Ruffin, Lawrence P. Park, Parisa Farahani et autres
BACKGROUND: The practice of obtaining follow-up blood cultures (FUBCs) in patients with gram-negative bloodstream infections (GN-BSI) remains controversial. The current study had two goals: (1) to internally validate our earlier findings of decreased mortality in patients with FUBCs and increased mortality in …
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Joshua T. Thaden, Felicia Ruffin, Lawrence P. Park, Parisa Farahani et autres
Supplementary Material 1
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Joshua T. Thaden, Felicia Ruffin, Lawrence P. Park, Parisa Farahani et autres
Supplementary Material 1
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Ritu Banerjee, Lauren Komarow, Yixuan Li, Donald Mau et autres
Importance: Novel blood culture diagnostics provide rapid antimicrobial susceptibility testing (AST) results for bacteria causing bloodstream infections (BSIs) but have unclear clinical impact. Objective: To evaluate clinical outcomes of blood culture testing using a rapid AST method compared with standard AST in …
fr, us, il, in, gr, es
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Ritu Banerjee, Lauren Komarow, Yixuan Li, Qiuwen Wu et autres
BACKGROUND: Novel, rapid blood culture diagnostics can provide faster antibiotic susceptibility results (AST) compared to standard methods but their impact on clinical outcomes is unclear and not assessed in many prospective clinical trials. METHODS: This study is a two-arm, multicenter, multinational, prospective …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Vance G. Fowler, Eric Cober, Yohei Doi, Andrea M. Hujer et autres
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Courtney Luterbach, Dana K. Pasquale, Heather Henderson, Eric Cober et autres
With limited treatments for carbapenem-resistant Klebsiella pneumoniae (CRKp), curtailing transmission is critical. We applied a network analysis using epidemiological admission data and bacterial genetics to characterize CRKp spread among patients in 16 acute care hospitals linked to 217 other healthcare facilities in …
us, sg
(code pays fourni par la source)
2025
article
OpenAlex
Steven Y. C. Tong, Vance G. Fowler, Lesley A. Skalla, Thomas L Holland
Importance: Staphylococcus aureus, a gram-positive bacterium, is the leading cause of death from bacteremia worldwide, with a case fatality rate of 15% to 30% and an estimated 300 000 deaths per year. Observations: Staphylococcus aureus bacteremia causes metastatic infection in more than …
au, us
(code pays fourni par la source)
2025
article
OpenAlex
Alexander J. Bahnick, David S. Ruppert, Gabriella A. Krisanic, Jeffrey I. Everitt et autres
Mesh suture is an emerging technology for closing high-tension soft tissue wounds. However, bulky mesh surgical knots can irritate surrounding tissue and harbor bacteria, leading to an increased risk of infection and palpability. Thus, a degradable knotless anchoring system is needed to …
us, it
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Alina Iovleva, Vance G. Fowler, Yohei Doi
us, jp
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Michael R. Jacobs, Caryn E. Good, Ayman M. Abdelhamed, Andrew R Mack et autres
ABSTRACT Ledaborbactam (formerly VNRX-5236), a bicyclic boronate β-lactamase inhibitor with activity against class A, C, and D β-lactamases, is under development as an orally bioavailable etzadroxil prodrug (VNRX-7145) in combination with ceftibuten for the treatment of urinary tract infections. At ceftibuten breakpoints …
us
(code pays fourni par la source)